Group 1 - The core point of the report is that Hunan Sailoxian Management Consulting Partnership (Limited Partnership) has acquired 58,606,962 shares of Qidi Pharmaceutical Group Co., Ltd., representing 24.47% of the total shares, through judicial auction, making it the controlling shareholder of the company [1][18][24] - The acquisition was executed following a court ruling and was completed on August 5, 2025, with the total payment amounting to 1,007.39 million yuan [20][19] - The report confirms that the acquisition does not aim to terminate the listing status of Qidi Pharmaceutical and that the company will continue to operate independently [17][23] Group 2 - Hunan Sailoxian was established on June 19, 2025, primarily engaged in investment management, with a registered capital of 405.57 million yuan [4][6] - The actual controller of Hunan Sailoxian is Jiang Lin, who holds 66.86% of the shares in the executing partner, Shanghai Sailoxian [5][6] - Qidi Pharmaceutical operates in the pharmaceutical manufacturing industry, focusing on the research and development of traditional Chinese medicine and Western medicine formulations, with over 140 drug varieties and more than 30 patents [24][25] Group 3 - The financial data of Shanghai Sailoxian shows total assets of 1,650.71 million yuan and total equity of 1,322.98 million yuan as of December 31, 2024, with a net profit of 93.54 million yuan [6][13] - The report indicates that there are no significant legal violations or administrative penalties against Hunan Sailoxian in the past five years [14][16] - The report outlines that there is a potential for competition between Qidi Pharmaceutical and Hunan Sailoxian's core enterprise, Hengchang Pharmaceutical, due to overlapping product lines [24][26]

Core Viewpoint - The report details the equity change of Citic Prudential Life Insurance Co., Ltd. in Canar Technology Co., Ltd., indicating a reduction in shareholding below 5% [1][2]. Group 1: Equity Change Details - Citic Prudential Life Insurance reduced its shareholding from 7,146,348 shares (5.8459%) to 6,112,253 shares (4.99998%) [8]. - The reduction involved selling 1,034,095 shares, which represents a decrease of 0.8459% in the total shareholding [8]. - The shares were sold through centralized bidding from July 30, 2025, to August 6, 2025 [9]. Group 2: Future Plans - Citic Prudential Life Insurance plans to continue reducing its holdings, with a maximum of 3,667,300 shares (up to 3% of the total share capital) to be sold within three months following the announcement made on April 24, 2025 [6][7]. - There are no plans for increasing shareholding in the next 12 months [6]. Group 3: Compliance and Disclosure - The report confirms that all necessary authorizations and approvals for the equity change have been obtained, ensuring compliance with relevant laws and regulations [1][2]. - Citic Prudential Life Insurance has committed to the accuracy and completeness of the report, taking legal responsibility for any misrepresentation [2][10].

Group 1 - The core point of the news is that Guangxi Heiwulei Food Group Co., Ltd. has signed a share transfer agreement with Guangxi Travel Health Industry Group Co., Ltd. to sell 20% of its shares in Heizhima (000716.SZ) [1] - Following the completion of the share transfer, the controlling shareholder of the company will change from Heiwulei Group to Guangxi Travel Health, and the actual controllers will shift to the State-owned Assets Supervision and Administration Commission of the Guangxi Zhuang Autonomous Region [1] - A voting rights waiver agreement has been signed, where the parties involved will unconditionally and irrevocably waive their voting rights corresponding to 17.66% of the company's shares, totaling 133 million shares [1] Group 2 - The company's stock will resume trading on August 11, 2025, at the market opening [2]

Core Viewpoint - The financial advisor, CITIC Securities, has verified the detailed equity change report of Tsinghua Unigroup Pharmaceutical Group Co., Ltd., confirming that the disclosed information is accurate, complete, and compliant with relevant laws and regulations [1][5][21]. Group 1: Overview of the Equity Change - The equity change involves the acquisition of 58,606,962 shares of Tsinghua Unigroup, representing 24.47% of the total share capital, making the acquirer the controlling shareholder [16][17]. - The acquisition was executed through a judicial auction, with the total payment amounting to 1,007.39 million yuan [21][22]. Group 2: Financial Status of the Acquirer - The acquirer, Hunan Sailoxian Management Consulting Partnership (Limited Partnership), was established on June 19, 2025, with a registered capital of 405.57 million yuan [5][6]. - The financial data of the acquirer shows total assets of 1,650.71 million yuan and total equity of 1,322.98 million yuan as of December 31, 2024 [13]. Group 3: Impact on Tsinghua Unigroup - Tsinghua Unigroup will maintain its independence as a listed company, with no plans to change its main business or make significant adjustments in the next 12 months [22][24]. - The acquirer has committed to avoiding any actions that would harm the interests of Tsinghua Unigroup and its minority shareholders [25][29]. Group 4: Compliance and Regulatory Aspects - The acquirer has adhered to all necessary legal procedures and obligations regarding the equity change, including the commitment to disclose any future changes in shareholding [16][22]. - There are no reported violations or legal issues concerning the acquirer in the past five years [14][15].

湖北超卓航空科技股份有限公司 简式权益变动报告书 上市公司名称：湖北超卓航空科技股份有限公司 股票上市地点：上海证券交易所 股票简称：超卓航科 股票代码：688237 信息披露义务人信息 信息披露义务人：航证科创投资有限公司 住所：北京市通州区滨惠北一街 3 号院 1 号楼 1 层 1-8-138 通讯地址： 北京市朝阳区中航产融大厦 32 层 3208 股份变动性质：持股比例降至 5%以下 签署日期：2025 年 8 月 8 日 信息披露义务人声明 一、信息披露义务人依据《中华人民共和国证券法》（以下简称为"《证券 法》"）、《上市公司收购管理办法》（以下简称"《收购管理办法》"）、《公 开发行证券的公司信息披露内容与格式准则第 15 号-权益变动报告书》（以下简 称"《准则 15 号》"）及其他相关的法律、法规和规范性文件编写本报告书。 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不违 反信息披露义务人公司章程或内部规则中的任何条款，或与之相冲突。 三、依据《证券法》、《收购管理办法》、《准则 15 号》的规定，本报告 书已全面披露信息披露义务人在湖北超卓航空科技股份有限公司中拥有权益的 ...

深圳市远望谷信息技术股份有限公司 简式权益变动报告书 股票简称：远望谷 股票代码：002161 信息披露义务人：徐玉锁 住所：广东省深圳市南山区 通讯地址：深圳市南山区粤海街道高新南十道 63 号高新区联合总部大厦 27 楼 一致行动人：陈光珠 住所：广东省深圳市南山区 通讯地址：深圳市南山区粤海街道高新南十道 63 号高新区联合总部大厦 27 楼 股份权益变动性质：股份减少（触及 5%整数倍） 本部分所述词语或简称的含义详见本报告书"释义" 一、本报告书系信息披露义务人依据《中华人民共和国证券法》 上市公司：深圳市远望谷信息技术股份有限公司 上市地点：深圳证券交易所 《上市公司收购管理办法》的规定，本报告 书已全面披露信息披露义务人在远望谷中拥有权益的股份变动情况； 截至本报告书签署日，除本报告书披露的信息外，信息披露义务人没有通过任 何其他方式增加或减少其在远望谷中拥有权益的股份； 四、信息披露义务人承诺本报告书不存在虚假记载、误导性陈述或重大遗漏， 并对其真实性、准确性、完整性承担个别和连带的法律责任； 五、本次权益变动是根据本报告书所载明的资料进行的。除本信息披露义务人 外，没有委托或者授权任何其他人 ...

Core Viewpoint - The report details a significant equity change involving Shanghai Dinghui Yuanlin Equity Investment Partnership (Limited Partnership), which has reduced its stake in Efort Intelligent Equipment Co., Ltd. to 5% as of August 7, 2025 [1][2]. Group 1: Equity Change Details - The equity change was executed through centralized bidding and block trading, resulting in a reduction of shares from 50,444,444 to 26,089,000, representing a decrease of 24,355,444 shares or approximately 4.67% of the total share capital [4][6]. - The information disclosing party has committed to full disclosure of the equity change and has not engaged in any other methods to increase or decrease its stake in Efort Intelligent Equipment Co., Ltd. [2][5]. Group 2: Future Plans - The information disclosing party announced a plan on July 9, 2025, to potentially reduce its holdings by up to 13,044,500 shares, which is not more than 2.5% of the total share capital, within the next 12 months [5][6]. - The planned reduction includes a specific timeframe where up to 5,217,800 shares may be sold through centralized bidding within three months following the announcement [5][6]. Group 3: Compliance and Legal Framework - The report adheres to the regulations set forth by the Securities Law, the Takeover Management Measures, and the relevant disclosure guidelines, ensuring that the information is accurate and complete [1][2]. - The disclosing party has confirmed that there are no restrictions such as pledges or freezes on the shares involved in this equity change [6][7].

新亚制程（浙江）股份有限公司简式权益变动报告书 新亚制程（浙江）股份有限公司 简式权益变动报告书 上市公司名称：新亚制程（浙江）股份有限公司 股票上市地点：深圳证券交易所 股票简称：ST 新亚 股票代码：002388 信息披露义务人名称：湖南湘材新材料合伙企业（有限合伙） 住所：湖南省长沙市岳麓区望岳街道杜鹃路 858 号奥克斯缤纷 广场 5 号地块 1 栋 910、911、923 房-197 号 股份变动性质：减少（降至上市公司总股本的 5%以下） 签署日期：二零二五年八月 新亚制程（浙江）股份有限公司简式权益变动报告书 信息披露义务人声明 一、本报告书系依据《中华人民共和国公司法》《中华人民共和国证券法》、 《上市公司收购管理办法》 《公开发行证券的公司信息披露内容与格式准则第 15 号—权益变动报告书》及相关法律、法规和规范性文件编写。 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不违 反信息披露义务人章程或内部规则中的任何条款，或与之相冲突。 三、依据《中华人民共和国公司法》 《中华人民共和国证券法》 《上市公司收 购管理办法》的规定，本报告书已全面披露信息披露义务人在新亚制程（浙江 ...

Group 1 - The announcement indicates that Fujian Shida Group Co., Ltd. has received a notice regarding the completion of the business deregistration of Fujian Jinxi Qiyuan Equity Investment Partnership (Limited Partnership) [1] - Jinxi Qiyuan held 41,614,600 shares of the company, representing 1.91% of the total share capital, which were acquired through judicial auction in August 2023 [1][2] - The shares held by Jinxi Qiyuan will be transferred to its partners through a non-trading transfer, with Fujian Chuantou remaining as a concerted action party [2][4] Group 2 - The transfer of shares will not result in a change of control for the company, nor will it affect the governance structure and daily operations [4] - All partners of Jinxi Qiyuan will continue to comply with relevant regulations regarding information disclosure and share reduction limits [4]

Core Viewpoint - The report details a significant reduction in shareholding by Beijing Yuan Cheng Asset Management Co., Ltd. in Shenzhen Hemei Group Co., Ltd., dropping below 5% ownership, which indicates a strategic shift in investment [1][6]. Group 1: Shareholding Changes - The information disclosure obligor reduced its shareholding in Shenzhen Hemei Group from 65,600,000 shares (5.002843%) to 65,562,699 shares (4.999998%), marking a decrease of 37,301 shares, which is approximately 0.002845% of the total share capital [6][8]. - The reduction in shareholding was executed through centralized bidding transactions between July 28, 2025, and August 4, 2025, with an average selling price of approximately 3.267 RMB per share [6][8]. Group 2: Purpose of Shareholding Change - The purpose of this shareholding change is attributed to the information disclosure obligor's financial arrangements and operational needs, indicating a strategic decision to liquidate part of its investment [5][6]. - The information disclosure obligor has no plans to increase its shareholding in the next 12 months, as stated in the report [9]. Group 3: Compliance and Legal Statements - The report confirms that the information disclosure obligor has complied with all relevant laws and regulations, ensuring that there are no false records or misleading statements [2][8]. - There are no restrictions on the rights associated with the shares held by the information disclosure obligor, such as pledges or freezes [7].